Matthew J. Memoli

Infectious Disease
33 Rockville Pike
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

The effect of personality on likelihood of contracting SARS-CoV-2 in the United States.

The effect of personality on likelihood of contracting SARS-CoV-2 in the United States.

Journal: Personality and individual differences
Published: July 14, 2026

ELISA-based quantification of neuraminidase in commercial influenza vaccines using virus-derived reference antigens.

ELISA-based quantification of neuraminidase in commercial influenza vaccines using virus-derived reference antigens.

Journal: Microbiology spectrum
Published: June 24, 2026

Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunity.

Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunity.

Journal: Science translational medicine
Published: August 06, 2025

Corrigendum to: An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice [Virology, volume 393/2 (2009) 539, 338 - 345.

Corrigendum to: An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice [Virology, volume 393/2 (2009) 539, 338 - 345.

Journal: Virology
Published: June 28, 2025

Development of a recombinant membrane protein ELISA for analyzing antibody responses against SARS-CoV-2 envelope proteins.

Development of a recombinant membrane protein ELISA for analyzing antibody responses against SARS-CoV-2 envelope proteins.

Journal: The Journal of biological chemistry
Published: June 27, 2025

Influenza neuraminidase active site proximity assay for rapid profiling of inhibitory antibodies and antigenic drift.

Influenza neuraminidase active site proximity assay for rapid profiling of inhibitory antibodies and antigenic drift.

Journal: NPJ vaccines
Published: January 14, 2025

A comparative analysis of COVID-19 seroprevalence rates, observed infection rates, and infection-related mortality.

A comparative analysis of COVID-19 seroprevalence rates, observed infection rates, and infection-related mortality.

Journal: Frontiers in public health
Published: September 30, 2024

Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease.

Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease.

Journal: Immunity
Published: June 15, 2024

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.

Journal: mBio
Published: January 09, 2024

Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.

Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.

Journal: Frontiers in immunology
Published: December 08, 2023

Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months.

Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months.

Journal: medRxiv : the preprint server for health sciences
Published: October 31, 2023

Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial.

Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial.

Journal: EBioMedicine
Published: August 13, 2022
Showing 1-12 of 68

Last Updated: 09/26/2026